trimethoprim has been researched along with Hyperpigmentation in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among the different modalities for treatment of cutaneous leishmaniasis, liquid nitrogen is considered an effective therapy with very mild side-effects." | 2.68 | A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. ( Abuloham, O; al-Majali, O; Bhowmik, KR; Hebeheba, H; Muhsen, M; Routh, HB, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Majali, O | 1 |
| Routh, HB | 1 |
| Abuloham, O | 1 |
| Bhowmik, KR | 1 |
| Muhsen, M | 1 |
| Hebeheba, H | 1 |
1 trial available for trimethoprim and Hyperpigmentation
| Article | Year |
|---|---|
A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis.
Topics: Administration, Cutaneous; Adolescent; Adult; Anti-Infective Agents; Antimony; Cicatrix; Cryosurgery | 1997 |